HU9602263D0 - Nowel thiazolidine-4-on derivatives - Google Patents
Nowel thiazolidine-4-on derivativesInfo
- Publication number
- HU9602263D0 HU9602263D0 HU9602263A HUP9602263A HU9602263D0 HU 9602263 D0 HU9602263 D0 HU 9602263D0 HU 9602263 A HU9602263 A HU 9602263A HU P9602263 A HUP9602263 A HU P9602263A HU 9602263 D0 HU9602263 D0 HU 9602263D0
- Authority
- HU
- Hungary
- Prior art keywords
- nowel
- thiazolidine
- derivatives
- nowel thiazolidine
- Prior art date
Links
- NOLHRFLIXVQPSZ-UHFFFAOYSA-N 1,3-thiazolidin-4-one Chemical class O=C1CSCN1 NOLHRFLIXVQPSZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19940038787 | 1994-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU9602263D0 true HU9602263D0 (en) | 1996-10-28 |
Family
ID=19405013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9602263A HU9602263D0 (en) | 1994-12-29 | 1996-08-16 | Nowel thiazolidine-4-on derivatives |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0748317A1 (en) |
| JP (1) | JPH09503792A (en) |
| KR (1) | KR960022486A (en) |
| CN (1) | CN1142227A (en) |
| AU (1) | AU4317396A (en) |
| CA (1) | CA2184174A1 (en) |
| HU (1) | HU9602263D0 (en) |
| WO (1) | WO1996020936A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970032857A (en) * | 1995-12-29 | 1997-07-22 | 김준웅 | Pharmaceutical composition |
| EP1082315A1 (en) | 1998-06-05 | 2001-03-14 | Icagen, Inc. | Potassium channel inhibitors |
| US6174908B1 (en) | 1999-05-10 | 2001-01-16 | Icagen, Inc. | Potassium channel inhibitors |
| AU4249700A (en) * | 1999-04-19 | 2000-11-02 | Sumitomo Pharmaceuticals Company, Limited | Hydroxamic acid derivative |
| US6506751B1 (en) | 1999-11-12 | 2003-01-14 | Millennium Pharmaceuticals, Inc. | Thiazolidinone compounds useful as chemokine inhibitors |
| US6713477B1 (en) | 2000-04-19 | 2004-03-30 | Sumitomo Pharmaceuticals Company, Limited | Hydroxamic acid derivatives |
| US7026344B2 (en) * | 2000-08-15 | 2006-04-11 | South Alabama Medical Science Foundation | Treating sickle cell disease |
| CA2428753C (en) | 2000-11-17 | 2013-05-21 | Idenix (Cayman) Limited | Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| WO2003009807A2 (en) | 2001-07-23 | 2003-02-06 | Galileo Laboratories, Inc. | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| HUP0500165A2 (en) | 2001-12-19 | 2006-09-28 | Atherogenics Inc | Chalcone derivatives and their use to treat diseases |
| WO2004108094A2 (en) | 2003-06-06 | 2004-12-16 | Atherogenics, Inc. | Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| USRE43833E1 (en) | 2003-11-21 | 2012-11-27 | Actelion Pharmaceuticals Ltd. | Thiazolidin-4-one derivatives |
| AU2004295047B2 (en) | 2003-11-21 | 2011-03-10 | Actelion Pharmaceuticals Ltd | 5-(benz- (Z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents |
| WO2005082872A1 (en) | 2004-03-02 | 2005-09-09 | Dainippon Sumitomo Pharma Co., Ltd. | Benzothiazin-3-one compound and intermediate therefor |
| ES2523401T3 (en) | 2006-11-23 | 2014-11-25 | Actelion Pharmaceuticals Ltd. | Intermediates of a new process for the preparation of 5-benzylidene-2-alkylimino-3- phenylthiazolidin-4-one derivatives |
| US8912340B2 (en) | 2006-11-23 | 2014-12-16 | Actelion Pharmaceuticals Ltd. | Process for the preparation of 2-imino-thiazolidin-4-one derivatives |
| CA2895172C (en) | 2012-08-17 | 2020-08-18 | Actelion Pharmaceuticals Ltd | Process for the preparation of|(2z,5z)-5-(3-chloro-4-((r)-2,3-dihydroxypropoxy)benzylidene)-2-(propylimino)-3-|(o-tolyl)thiazolidin-4-one and intermediate used in said process |
| EP4039676A4 (en) * | 2019-10-02 | 2024-04-03 | Klotho Sciences | Compound for inducing expression of anti-aging gene klotho and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4992455A (en) * | 1987-05-22 | 1991-02-12 | Sumitomo Pharmaceuticals Company, Limited | Thiazolidin-4-one derivatives useful for treating diseases caused by platelet activating factor |
| DE3875073T2 (en) * | 1987-11-20 | 1993-03-11 | Hoechst Roussel Pharma | 3- (4 (1-SUBSTITUTED-4-PIPERAZINYL) BUTYL) -4-THIAZOLIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT. |
| JPH01190679A (en) * | 1988-01-22 | 1989-07-31 | Sumitomo Pharmaceut Co Ltd | Optically active novel thiazolidine-4-one derivative and acid-addition salt thereof |
-
1995
- 1995-12-28 KR KR1019950061220A patent/KR960022486A/en not_active Application Discontinuation
- 1995-12-29 WO PCT/KR1995/000183 patent/WO1996020936A1/en not_active Application Discontinuation
- 1995-12-29 AU AU43173/96A patent/AU4317396A/en not_active Abandoned
- 1995-12-29 EP EP95941921A patent/EP0748317A1/en not_active Withdrawn
- 1995-12-29 CA CA002184174A patent/CA2184174A1/en not_active Abandoned
- 1995-12-29 JP JP8520863A patent/JPH09503792A/en active Pending
- 1995-12-29 CN CN95191872A patent/CN1142227A/en active Pending
-
1996
- 1996-08-16 HU HU9602263A patent/HU9602263D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2184174A1 (en) | 1996-07-11 |
| CN1142227A (en) | 1997-02-05 |
| AU4317396A (en) | 1996-07-24 |
| EP0748317A1 (en) | 1996-12-18 |
| JPH09503792A (en) | 1997-04-15 |
| WO1996020936A1 (en) | 1996-07-11 |
| KR960022486A (en) | 1996-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA952413B (en) | 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives | |
| IL114759A0 (en) | Hydroxyalkylamine derivatives | |
| HK1002762A1 (en) | Alumino-silicate derivatives | |
| IL112721A0 (en) | Azole derivatives | |
| GB9511077D0 (en) | 17B-Substituted-6-azasteroid derivatives | |
| EP0708091A3 (en) | Indoloylguanidine derivatives | |
| HU9503384D0 (en) | Pyrrol derivatives | |
| ZA953356B (en) | Benzocycloalkylazolethione derivatives | |
| HU9602263D0 (en) | Nowel thiazolidine-4-on derivatives | |
| EP0747348A4 (en) | Aminoalkylcyclopropane derivative | |
| EP0692482A3 (en) | 1-pyridyltetrazolinone derivatives | |
| GB9411088D0 (en) | Hydroxylamine derivatives | |
| GB2295614B (en) | Novel 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivatives | |
| IL112519A0 (en) | 5-heteroarylindole derivatives | |
| ZA954125B (en) | Novel dialkoxy-pyridinyl-benzimidazole derivatives | |
| HU9503339D0 (en) | Amino-cyclopentane derivative | |
| GB9511365D0 (en) | Pyridazino-indole derivatives | |
| HU9503582D0 (en) | Thienopyridon derivatives | |
| ZA959662B (en) | Antineoplastic cyclolignan derivatives | |
| GB2287463B (en) | Bis-anthracycline derivatives | |
| GB2291425B (en) | 7-Diazo-beta-lactam derivatives | |
| IL114072A0 (en) | Fungicidal 5-imino-2- imidazoline derivatives | |
| GB9411860D0 (en) | Foundry core-shooter | |
| GB9507400D0 (en) | Silyloxy-cyclopropyl-azolyl derivatives | |
| GB9410986D0 (en) | Imidazopiperidine derivatives |